Search results for "Animal"

showing 10 items of 22159 documents

Haliotis tuberculata hemocyanin (HtH): analysis of oligomeric stability of HtH1 and HtH2, and comparison with keyhole limpet hemocyanin KLH1 and KLH2

2000

The multimeric/higher oligomeric states of the two isoforms of Haliotis tuberculata hemocyanin (HtH1 and HtH2) have been assessed by transmission electron microscopy (TEM) of negatively stained specimens, for comparison with previously published structural data from keyhole limpet hemocyanin (KLH1 and KLH2) [see Harris, J.R., Gebauer, W., Guderian, F.U., Markl, J., 1997a. Keyhole limpet hemocyanin (KLH), I: Reassociation from Immucothel followed by separation of KLH1 and KLH2. Micron, 28, 31-41; Harris, J.R., Gebauer, W., Söhngen, S.M., Nermut, M.V., Markl, J., 1997b. Keyhole limpet hemocyanin (KLH). II: Characteristic reassociation properties of purified KLH1 and KLH2. Micron, 28, 43-56; H…

medicine.medical_treatmentProtein subunitMagnesium ChlorideGeneral Physics and Astronomychemistry.chemical_elementCalciumOligomerCalcium Chloridechemistry.chemical_compoundStructural BiologymedicineAnimalsProtein IsoformsGeneral Materials ScienceMagnesium ionbiologyMagnesiumHemocyaninCell BiologyNegative stainMicroscopy ElectronCrystallographychemistryMolluscaHemocyaninsbiology.proteinBiophysicsKeyhole limpet hemocyaninMicron
researchProduct

A single mutation in the recombinant light chain of tetanus toxin abolishes its proteolytic activity and removes the toxicity seen after reconstituti…

1994

Specific proteolysis by the tetanus toxin light chain of a vesicle-associated membrane protein (VAMP) involved in exocytosis is thought to underlie its intracellular blockade of neurotransmitter release. To substantiate this mechanism, recombinant light chain was expressed as a maltose binding protein-light chain fusion product in Escherichia coli. After purification of affinity chromatography and cleavage with factor Xa, the resultant light chain was isolated and its identity confirmed by Western blotting and N-terminal sequencing. It exhibited activity similar to that of the native light chain in proteolyzing its target in isolated bovine small synaptic vesicles and in hydrolyzing a 62-re…

medicine.medical_treatmentRecombinant Fusion ProteinsMolecular Sequence DataNeurotoxinsGlutamic AcidMaltose bindingNerve Tissue ProteinsIn Vitro TechniquesImmunoglobulin light chainBiochemistrySynaptic vesicleExocytosislaw.inventionR-SNARE ProteinsMiceStructure-Activity RelationshipAffinity chromatographyGlutamatesTetanus ToxinlawThermolysinEndopeptidasesmedicineEscherichia coliAnimalsAmino Acid SequenceProteaseBase SequenceChemistryMembrane ProteinsMolecular biologyPeptide FragmentsRecombinant DNAMutagenesis Site-DirectedCattleBiochemistry
researchProduct

On the Ultrastructure and Function of Rhogocytes from the Pond Snail Lymnaea stagnalis

2015

Rhogocytes, also termed “pore cells”, occur as solitary or clustered cells in the connective tissue of gastropod molluscs. Rhogocytes possess an enveloping lamina of extracellular matrix and enigmatic extracellular lacunae bridged by cytoplasmic bars that form 20 nm diaphragmatic slits likely to act as a molecular sieve. Recent papers highlight the embryogenesis and ultrastructure of these cells, and their role in heavy metal detoxification. Rhogocytes are the site of hemocyanin or hemoglobin biosynthesis in gastropods. Based on electron microscopy, we recently proposed a possible pathway of hemoglobin exocytosis through the slit apparatus, and provided molecular evidence of a common phylog…

medicine.medical_treatmentSnailslcsh:MedicineCoated vesicleFresh WaterLymnaea stagnalisSnailBiologyHemoglobinsHemolymphbiology.animalHemolymphExtracellularmedicineAnimalslcsh:ScienceIn Situ HybridizationLymnaeaUltrasonographyMultidisciplinaryBiomphalarialcsh:RHemocyaninAnatomybiology.organism_classificationLymnaeaCell biologyMicroscopy ElectronHemocyaninsUltrastructurelcsh:QCadmiumResearch ArticlePLOS ONE
researchProduct

Dendritic Cell-Specific Deletion of β-Catenin Results in Fewer Regulatory T-Cells without Exacerbating Autoimmune Collagen-Induced Arthritis.

2015

Dendritic cells (DCs) are professional antigen presenting cells that have the dual ability to stimulate immunity and maintain tolerance. However, the signalling pathways mediating tolerogenic DC function in vivo remain largely unknown. The beta-catenin pathway has been suggested to promote a regulatory DC phenotype. The aim of this study was to unravel the role of beta-catenin signalling to control DC function in the autoimmune collagen-induced arthritis model (CIA). Deletion of beta-catenin specifically in DCs was achieved by crossing conditional knockout mice with a CD11c-Cre transgenic mouse line. Bone marrow-derived DCs (BMDCs) were generated and used to study the maturation profile of …

medicine.medical_treatmentT cellAntigen-Presenting Cellslcsh:Medicinechemical and pharmacologic phenomenaBiologyT-Lymphocytes RegulatoryImmune toleranceMiceImmune TolerancemedicineAnimalsHumansCytotoxic T cellAntigen-presenting celllcsh:ScienceCollagen Type IIbeta CateninMice KnockoutMultidisciplinarylcsh:Rhemic and immune systemsDendritic CellsDendritic cellArthritis ExperimentalToll-Like Receptor 2Toll-Like Receptor 4TLR2Cytokinemedicine.anatomical_structureImmunologyTh17 Cellslcsh:QCD8Research ArticleSignal TransductionPLoS ONE
researchProduct

Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 developm…

1998

IL-18 is a recently described cytokine that shares biological activities with IL-12 in driving the development of Th1-type T cells. As dendritic cells (DC) are very potent inducers of T cell proliferation and differentiation we wondered whether they utilize IL-18 as a factor driving Th1 development. We demonstrate by Northern blot and reverse transcription-PCR that various subtypes of human and murine DC as well as the DC-line XS contain IL-18 mRNA. When supernatants of either enriched Langerhans cells (LC) or bone marrow-derived DC were analyzed for production of IL-18 protein, IL-18 production was detected in an IL-18-specific ELISA. To assess whether the IL-18 protein released by DC is f…

medicine.medical_treatmentT cellCellular differentiationImmunologyMice TransgenicBiologyCell LineMicemedicineAnimalsHumansImmunology and AllergyRNA MessengerNorthern blotInterleukin-18Cell DifferentiationDendritic CellsDendritic cellTh1 CellsBlotting NorthernInterleukin-12Molecular biologyCulture MediaCytokinemedicine.anatomical_structureConcanavalin ALangerhans CellsInterleukin 12biology.proteinInterleukin 18European Journal of Immunology
researchProduct

Dendritic cells lentivirally engineered to overexpress interleukin-10 inhibit contact hypersensitivity responses, despite their partial activation in…

2010

Background Dendritic cells (DCs) constitute an attractive target for immunotherapeutic approaches. Because DCs are largely refractory to transfection with plasmid DNA, several viral transduction protocols were established. The potential side-effects of lentiviral transduction on the phenotype and activation state of DCs left unstimulated after transduction have not been assessed. There is a need to analyse these parameters as a result of the requirement of using DCs with a low activation state for therapeutic strategies intended to induce tolerance. Methods Lentivirally-transduced bone marrow (BM)-derived DCs (LV-DCs) in comparison with mock-transduced (Mock-DCs) and untreated DCs were anal…

medicine.medical_treatmentT cellGenetic enhancementT-Lymphocyteschemical and pharmacologic phenomenaBiologyLymphocyte ActivationTransduction (genetics)MiceStress PhysiologicalTransduction GeneticDrug DiscoveryGeneticsmedicineAnimalsMolecular BiologyGenetics (clinical)Mice Inbred BALB CInterleukinhemic and immune systemsImmunotherapyTransfectionDendritic CellsCell biologyInterleukin-10Mice Inbred C57BLInterleukin 10Cytokinemedicine.anatomical_structureImmunologyDermatitis Allergic ContactMolecular MedicineFemaleImmunotherapyGenetic EngineeringThe journal of gene medicine
researchProduct

Differential expression of mRNA encoding interleukin-12 p35 and p40 subunitsin situ

1994

Interleukin-12 (IL-12) is a heterodimeric cytokine that plays an important role in the regulation of the immune response. For biological activity the expression of both subunits of IL-12, p35 and p40, is required. Moreover, in the mouse the p40 chain of IL-12 specifically inhibits the effects of the IL-12 heterodimer. In the present study we have analyzed by in situ hybridization the expression of the p35 and p40 mRNA in the spleens of BALB/c and mutant (SCID, nude, beige) mice, unstimulated and after in vivo stimulation with lipopolysaccharide (LPS) and with staphylococcal enterotoxin B (SEB). In unstimulated spleens of BALB/c mice p35 and p40 mRNA were only detectable in a few strongly st…

medicine.medical_treatmentT cellImmunologyGene ExpressionMice NudeSpleenMice SCIDIn situ hybridizationBiologyMiceGene expressionmedicineAnimalsImmunology and AllergyRNA MessengerIn Situ HybridizationB cellMice Inbred BALB CMessenger RNAMacrophageshemic and immune systemsInterleukin-12Molecular biologyMice Mutant Strainsmedicine.anatomical_structureCytokineInterleukin 12SpleenEuropean Journal of Immunology
researchProduct

The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment

2020

The serine/threonine kinase glycogen synthase kinase-3 (GSK-3) was initially identified because of its key role in the regulation of glycogen synthesis. However, it is now well-established that GSK-3 performs critical functions in many cellular processes, such as apoptosis, tumor growth, cell invasion, and metastasis. Aberrant GSK-3 activity has been associated with many human diseases, including cancer, highlighting its potential therapeutic relevance as a target for anticancer therapy. Recently, newly emerging data have demonstrated the pivotal role of GSK-3 in the anticancer immune response. In the last few years, many GSK-3 inhibitors have been developed, and some are currently being te…

medicine.medical_treatmentT cellsReviewmacromolecular substancesNK cellsMetastasisGlycogen Synthase Kinase 3MiceImmune systemCancer immunotherapyGSK-3NeoplasmsPD-1medicineAnimalsHumanscancerGlycogen synthaselcsh:QH301-705.5GSK-3biologyKinasebusiness.industryCancerGeneral MedicineImmunotherapymedicine.diseasesmall molecule inhibitorsDisease Models Animalglycogen synthase kinase-3 (GSK-3)lcsh:Biology (General)Cancer researchbiology.proteinCTLA-4immunotherapybusiness
researchProduct

An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors.

2019

A one-two, CAR-T cell punch Chimeric antigen receptor (CAR)–T cells have been clinically effective in killing certain hematological malignancies, but achieving long-term patient responses for solid tumors remains a challenge. Reinhard et al. describe a two-part “CARVac” strategy to overcome poor CAR-T cell stimulation and responses in vivo. They introduce the tight junction protein claudin 6 (CLDN6) as a new CAR-T cell target and designed a nanoparticulate RNA vaccine encoding a chimeric receptor directed toward CLDN6. This lipoplex RNA vaccine promotes CLDN6 expression on the surface of dendritic cells, which in turn stimulates and enhances the efficacy of CLDN6-CAR-T cells for improved tu…

medicine.medical_treatmentT-LymphocytesCellCancer VaccinesImmunotherapy AdoptiveMiceAntigenmedicineAnimalsHumansClaudinB cellMice Inbred BALB CVaccines SyntheticMultidisciplinaryReceptors Chimeric AntigenTight junctionChemistryRNAImmunotherapyChimeric antigen receptorMice Inbred C57BLmedicine.anatomical_structureClaudinsCancer researchRNAFemaleScience (New York, N.Y.)
researchProduct

Harnessing dendritic cells in cancer.

2011

Dendritic cells (DCs) are central to the initiation of tumor-specific immune responses. However, the tumor microenvironment generates immunosuppressive cells and soluble mediators that compromise DC functions and limit the success of DC-based therapies. Progress in understanding DC metabolism in cancer is uncovering novel therapeutic targets that could restore DC capacity to prime T cells and trigger effective anticancer responses. Accumulating evidence also indicates that conventional chemo- and radiotherapy protocols can cause DC activation, enhance antigen cross-presentation, selectively eliminate immunosuppressive cells and revert the immunosuppression state caused by cancer, suggesting…

medicine.medical_treatmentT-LymphocytesImmunologyAntineoplastic AgentsBiologyLymphocyte ActivationCancer VaccinesImmune systemAntigenChemoimmunotherapyAntigens NeoplasmNeoplasmsmedicineTumor MicroenvironmentImmunology and AllergyAnimalsHumansTumor microenvironmentInnate immune systemCancerImmunotherapyDendritic CellsAcquired immune systemmedicine.diseaseCell biologyKiller Cells NaturalDisease Models AnimalImmunotherapySeminars in immunology
researchProduct